Current Status of Dewayne Johnson
Dewayne Johnson, the former school groundskeeper who became the first plaintiff to prevail against Monsanto (now Bayer) in a glyphosate cancer lawsuit, is alive. As of the latest available public records, he continues to receive ongoing medical monitoring and legal support tied to his non-Hodgkin lymphoma diagnosis. This status clarification summarizes verified information about his health, legal outcomes, and public presence to date.
Background on the Monsanto Lawsuit
Johnson worked as a groundskeeper in California when he was diagnosed with non-Hodgkin lymphoma in 2014. He filed a lawsuit claiming that exposure to Monsanto's glyphosate-based herbicides, including Roundup, was a substantial factor in his cancer. In 2018, a San Francisco jury awarded him $289 million in damages, later reduced to a reduced settlement. The case drew widespread attention and prompted hundreds of similar claims.
Key Trial and Settlement Highlights
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Initial Award (2018) | $289 million (compensatory and punitive) | Court Judgment |
| Final Settlement | Approximately $78 million after reduction and appeal | Court Records |
| Year of Diagnosis | 2014 | Medical and Legal Documents |
| Plaintiff Verdict | Monsanto liable; product labeling inadequate | Trial Jury Decision |
| Bayer Acquisition | Bayer acquired Monsanto in 2018, inheriting litigation | Corporate Filing |
Health and Current Whereabouts
Although Johnson's lymphoma diagnosis and treatment were extensively documented during litigation, recent public statements and interviews indicate he remains alive and continues to manage his health with medical support. He has largely stepped back from the public spotlight, focusing on treatment and recovery rather than new legal actions.
Ongoing Litigation and Class Actions
Johnson's case was the first successful jury trial against Monsanto over glyphosate. While he is alive and his personal case has moved toward resolution, thousands of other lawsuits remain pending. Class actions and individual claims continue to reference his verdict as persuasive precedent, though outcomes vary by jurisdiction and evidence.
Reputation, Public Perception, and Media Coverage
Johnson's story shaped public discourse on pesticide safety and corporate accountability. Media coverage initially framed him as a sympathetic plaintiff, while Bayer has consistently defended glyphosate's safety profile. Over time, the case has become a touchstone in debates over chemical regulation, product liability, and transparency in risk communication.
Comparative Snapshot: Key Figures in Glyphosate Litigation
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Dewayne Johnson | Plaintiff in first successful Monsanto trial; alive | Court and Public Records |
| Initial Award | $289 million (2018), later reduced | Judicial Documents |
| Final Payout | Approximately $78 million settled | Legal Settlement Filings |
| Bayer Resolution | Settlement fund established for future claims | Company Press Release |
| Ongoing Cases | Thousands of suits unresolved worldwide | Litigation Tracker Data |
Conclusion
Dewayne Johnson is alive and continues to receive medical treatment following his landmark legal victory against Monsanto. While his high-profile case set a precedent and fueled global debates about glyphosate, his current focus remains on health and stability. The available evidence supports that he is alive, and the long-term implications of his case will likely influence future litigation and policy for years to come.